Balasa Dinverno & Foltz LLC Jazz Pharmaceuticals PLC Transaction History

Balasa Dinverno & Foltz LLC

  • $1.58 Billion
  • Q3 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Apr 30, 2020
SELL
$87.74 - $152.74 $384,037 - $668,542
-4,377 Closed
0 $0
Q4 2019

Jan 22, 2020
BUY
$117.65 - $153.73 $140,591 - $183,707
1,195 Added 37.55%
4,377 $653,000
Q3 2019

Nov 06, 2019
BUY
$125.18 - $143.24 $398,322 - $455,789
3,182 New
3,182 $408,000

Others Institutions Holding JAZZ

# of Institutions
511
Shares Held
57.8M
Call Options Held
188K
Put Options Held
133K
View Full List

About Jazz Pharmaceuticals plc

JAZZ Quotes by TradingView
  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.63B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Balasa Dinverno & Foltz LLC Portfolio

Follow Balasa Dinverno & Foltz LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balasa Dinverno & Foltz LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balasa Dinverno & Foltz LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email